Regeneron Pharmaceuticals (NQ: REGN )
973.80
+5.80
(+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Headline News about Regeneron Pharmaceuticals
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
Via Benzinga
Exposures
Product Safety
Via Benzinga
Via Benzinga
The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 10 Experts
February 27, 2024
Via Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
February 22, 2024
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $6,400 Today
February 06, 2024
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 12, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|